Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter

This article was originally published in The Gray Sheet

Executive Summary

Board of directors authorizes repurchase up to 12 mil. shares of common stock "for use in employee stock option, stock repurchase and other benefit plans, and other authorized corporate purposes." The repurchase plan extends a November 1990 board authorization for the purchase of up to 13.5 mil. shares. Baxter has already bought back 12.5 mil. shares under the 1990 and prior grants of authority.
UsernamePublicRestriction

Register

MT000346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel